Sun Pharma stock down 13.7 per cent in the last 2 days over fresh whistle-blower complaint losing almost Rs 14,000 cr in m-cap going to its lowest point in almost six years. Wipro’s board announced a bonus of 1:3 alongwith an interim dividend of Re 1/share. | Photo Credit: Thinkstock 1. Sun Pharma – Corporate governance concerns continues to ail stock Stock down 13.7 per cent in the last 2 days over fresh whistle-blower complaint losing almost Rs 14,000 cr in m-cap going to its lowest point in almost six years. A…
Read MoreBusiness Top 5: Corporate governance issue continues to drag Sun Pharma stocks down; Wipro announces 1:3 bonus
